• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

David Kaplan elected to National Academy of Engineering

Bioengineer by Bioengineer
February 24, 2021
in Science News
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Tufts biomedical engineer and researcher is recognized for his contributions to silk-based materials for tissue engineering and regenerative medicine

IMAGE

Credit: Alonso Nichols

David Kaplan, the Stern Family Professor of Engineering, a Distinguished Professor, and chair of the Department of Biomedical Engineering, has been elected to the National Academy of Engineering in recognition of his contributions to silk-based materials for tissue engineering and regenerative medicine. Election to the National Academies is one of the foremost professional recognitions available to engineers, scientists, and medical experts.

“On behalf of my past and current students and colleagues here at Tufts, it is an honor to be recognized by the National Academy of Engineering,” said Kaplan.

Kaplan’s lab is leading efforts in applying tissue engineering to cellular agriculture (i.e. cell grown meat), the development of 3D brain-like environments in the lab to study neurological diseases and treatments, and the regeneration of tissues, organs and limbs. He is also pioneering methods to manufacture biocompatible medical devices from silk.

Kaplan is the director of the Initiative for Neural Science, Disease & Engineering. For 15 years, he directed the National Institutes of Health P41 Tissue Engineering Resource Center as a partnership with Columbia University. He holds faculty appointments in Tufts School of Medicine, the Tufts School of Dental Medicine, the Department of Chemistry, and the Department of Chemical and Biological Engineering.

Kaplan has published more than 900 peer-reviewed papers and edited eight books. He is a highly cited expert in biomaterials and biotechnology and a pioneer in the use of silk as a novel option in the field of degradable medical polymers.

In 2019, a report in Nature Biotechnology recognized him as one of the top 20 translational researchers in biotechnology worldwide. He is editor-in-chief of the journal ACS Biomaterials Science and Engineering.

Kaplan is also a fellow of the American Institute of Medical and Biological Engineering and the International Academy of Medical and Biological Engineering. He was recently named co-chair of the first Gordon Research Conference on silk-based materials, slated for August.

###

Media Contact
Mike Silver
[email protected]

Tags: Biomedical/Environmental/Chemical EngineeringCell BiologyChemistry/Physics/Materials SciencesFood/Food ScienceMaterialsneurobiologyOrthopedic MedicinePharmaceutical SciencePharmaceutical SciencesPolymer Chemistry
Share13Tweet8Share2ShareShareShare2

Related Posts

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

February 7, 2026

Multidisciplinary Evidence-Based Guidelines for Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease

February 7, 2026

Early Tuberculosis Treatment Lowers Sepsis Mortality in People with HIV

February 7, 2026

Deep Learning Uncovers Tetrahydrocarbazoles as Potent Broad-Spectrum Antitumor Agents with Click-Activated Targeted Cancer Therapy Approach

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

Multidisciplinary Evidence-Based Guidelines for Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease

Early Tuberculosis Treatment Lowers Sepsis Mortality in People with HIV

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.